Exchange: NASDAQ·Updated 06:15 AM EDT
RLMD logo

RLMDRelmada Therapeutics Inc

$4.81
$0.19
(3.80%)
Pre-Market
Prev Close $5.00
EarningsAug 6
Mkt Cap$549.62M
Vol25.00

About

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
17

Frequently Asked Questions

What is Market Cap of Relmada Therapeutics Inc?
What is the 52-week high for Relmada Therapeutics Inc?
What is the 52-week low for Relmada Therapeutics Inc?
What is Relmada Therapeutics Inc stock price today?
What was Relmada Therapeutics Inc stock price yesterday?
What is the PE ratio of Relmada Therapeutics Inc?
What is the Price-to-Book ratio of Relmada Therapeutics Inc?
What is the 50-day moving average of Relmada Therapeutics Inc?
How many employees does Relmada Therapeutics Inc have?

Advertisement|Remove ads.